Cargando…
ALDH3A2, ODF2, QSOX2, and MicroRNA-503-5p Expression to Forecast Recurrence in TMPRSS2-ERG-Positive Prostate Cancer
Following radical surgery, patients may suffer a relapse. It is important to identify such patients so that therapy tactics can be modified appropriately. Existing stratification schemes do not display the probability of recurrence with enough precision since locally advanced prostate cancer (PCa) i...
Autores principales: | Kobelyatskaya, Anastasiya A., Kudryavtsev, Alexander A., Kudryavtseva, Anna V., Snezhkina, Anastasiya V., Fedorova, Maria S., Kalinin, Dmitry V., Pavlov, Vladislav S., Guvatova, Zulfiya G., Naberezhnev, Pavel A., Nyushko, Kirill M., Alekseev, Boris Y., Krasnov, George S., Bulavkina, Elizaveta V., Pudova, Elena A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569942/ https://www.ncbi.nlm.nih.gov/pubmed/36232996 http://dx.doi.org/10.3390/ijms231911695 |
Ejemplares similares
-
Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2021) -
Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2023) -
Somatic Mutation Profiling in Head and Neck Paragangliomas
por: Savvateeva, Maria, et al.
Publicado: (2022) -
Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939
por: Pudova, Elena, et al.
Publicado: (2022) -
NETO2 Is Deregulated in Breast, Prostate, and Colorectal Cancer and Participates in Cellular Signaling
por: Fedorova, Maria S., et al.
Publicado: (2020)